Application 201846
- Type
- ANDA
- Sponsor
- APOTEX INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | AZELASTINE HYDROCHLORIDE | AZELASTINE HYDROCHLORIDE | SPRAY, METERED;NASAL | EQ 0.1876MG BASE/SPRAY | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 60505-0848 | Azelastine Hydrochloride | Azelastine Hydrochloride | Apotex Corp. | ANDA | Current |
| 60505-0848 | Azelastine Hydrochloride | Azelastine Hydrochloride | Apotex Corp. | ANDA | Current |
| 60505-0848 | Azelastine Hydrochloride | Azelastine Hydrochloride | Apotex Corp. | ANDA | Current |
| 60505-0848 | Azelastine Hydrochloride | Azelastine Hydrochloride | Apotex Corp. | ANDA | Current |
| 68071-2498 | Azelastine Hydrochloride | Azelastine Hydrochloride | NuCare Pharmaceuticals,Inc. | ANDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 43375 | ORIG | 2012-10-09 |